UNCONTROLLED WHEN PRINTED

Definition

Sepsis is broadly defined as a life-threatening condition caused by a hyperacute, dysregulated inflammatory response to infection, inability to restore homeostasis, and the presence of organ dysfunction (15). 

Clinical features

Clinical features for sepsis are nonspecific and are a result of the body's dysregulated response to infection. Commonly cited diagnostic features across diagnostic tests include:

  1. signs and symptoms of an infection (16);
  2. signs of loss of perfusion (16);
  3. leukocytosis with a white blood cell count >12,000 or <4000 per cubic millimeter (15);
  4. temperature <36 or >38 degrees Celsius (15);
  5. hypotension (systolic <90 or mean arterial pressure <65) (16);
  6. tachycardia defined as heart rate >90 (15);
  7. tachypnoea defined as respiratory rate >20 or PaC02>32 mmHg (15); and,
  8. hyperlactatemia with a serum lactate level above 4 mmol/L (16).

Historically, the accepted criteria centered around the Systemic Inflammatory Response Syndrome (SIRS) protocol, with tools including National Early Warning Score (NEWS), Sepsis-related Organ Failure Assessment (SOFA), and quick-SOFA (qSOFA); however, SIRS criteria have been criticised for focusing solely upon inflammatory excess, which is often present in non-septic patients (15).  In 2016 sepsis was redefined by international consensus under the SEPSIS-3 paper, which differentiates sepsis from septic shock (15).

The SEPSIS-3 criteria definition for sepsis is an acute change in SOFA score of two or more, with the score presumed to be zero in patients with no known pre-existing disease (15). The full SOFA score cannot be determined in the pre-hospital environment as three of the seven SOFA elements require laboratory tests unavailable to paramedics, with another two having limited applicability. 

Epidemiology

Sepsis has a high mortality rate, with estimates ranging between 10-52%, and approximately 40% for septic shock (15,16).  Studies have variously found sepsis present in five to six percent of all-causes mortality (17,18).  The SEPSIS-3 paper suggested that sepsis is the leading cause of mortality and morbidity globally, with 48.9 million cases and 11 million deaths reported in 2017 (15,19).

Classifications

Sepsis in the early stage of the pathology is classified simple as sepsis, while in the later stage of the disease is it classified as severe sepsis (also known as septic shock).  The early-stage classification of sepsis has been historically defined as infection in conjunction with SIRS (16). SIRS is a form of dysregulated inflammatory syndrome, and is itself frequently defined as two or more abnormalities in temperature, heart rate, respiration, or white blood count (15,16).  The latter-stage classification of severe sepsis is a type of distributive shock where sepsis has progressed to inadequate tissue perfusion, and is associated with higher mortality rates (16).

Pathology

Sepsis is a malignant, systemic hyper-inflammatory response to infection, characterised by an exaggerated immune response and a failure to return to homeostasis (20).  The exact mechanisms leading localised inflammation to accelerate systemically and form sepsis are unknown; however, it is believed to be a combination of four contributing factors. Firstly, there is an excessive release of inflammatory mediators.  Secondly, there is a greater activation of the complement system, which in turn attracts more leucocytes and further increases inflammation.  Thirdly, inflammation may be directly stimulated by some pathogens, as bacterial cell walls have inflammatory properties.  Finally, there may be a genetic component, as certain alleles have been linked to increased inflammation (20,21).  Pulmonary inflammation may lead to acute pulmonary oedema formation, decreasing external respiration and causing hypoxaemia (21).  Systemically, inadequate perfusion leads to multiple organ dysfunction – particularly the central nervous and renal systems.  Without correction, mortality results from shock and multiple organ failure.

Evaluation and risk assessment

Sepsis should be considered in all patients presenting with dysthermia and hypotension, and a fluid challenge immediately provided. Under the SEPSIS-3 criteria (15), sepsis has progressed to septic shock when the patient, after volume resuscitation, additionally:

  • requires vasopressors to maintain a mean arterial pressure >65mmHg; and,
  • has a serum lactate >2mmol/L.

Currently, only two services (ACTAS and, to a limited extent, QAS) provide serum lactate measurement (1,12).  Therefore, formal diagnosis of septic shock is not possible by practitioners from other services.  For faster and frequent assessment, the SEPSIS-3 paper recommends use of a test with lower specificity and sensitivity but increased ease of use, the qSOFA score.  Under this system the presence of any two of the following factors is sufficient to make the diagnosis of shock:

  • respiratory rate >22;
  • altered mentation;
  • systolic blood pressure <100mmHg (15).

However, the qSOFA score has been found to have poor sensitivity (22). Any patient presenting with these three abnormalities should be treated as time critical and, where transport times over 3 hours exist, consultation for prehospital administration of antibiotics should be considered by the paramedics (23–25).

Risk factors for sepsis include a history of bacterial infections, advanced age, immunosuppression, obesity, diabetes, cancer, pneumonia, and genetic factors.  Recent hospital admission is a significant risk factor, with one study finding that 50 percent of septic intensive care admissions suffered from a nosocomial infection (16).  

A 2019 meta-analysis of thirteen studies (n=33,863) showed no differences in mortality between administration of antibiotics within 60 minutes of diagnosis, and administration between 60 and 180 minutes of diagnosis; however, the quality of evidence was rates as low (23).  Delays of over 180 minutes have been associated with increased mortality (24,25).

Differential diagnoses

There are a multitude of conditions that can closely mimic a sepsis presentation, highlighting the necessity to perform extensive history taking and observations in order to differentiate and isolate likely causes of symptoms (16,26). Some of the most common imitators of sepsis include other forms of shock, hyperthyroidism, addisonian crisis, pulmonary embolism, haemorrhage, pericarditis, myocarditis, pancreatitis, and ethanol withdrawal syndromes (26,27).


References

  • Wilkinson-Stokes, M. (2020), A Comparison of Australasian Jurisdictional Ambulance Services’ Paramedic Clinical Practice Guidelines Series. Paper 2: Adult Sepsis. Australian Catholic University.
  • Paramedics Australasia. Paramedicine Role Descriptions [Internet]. Melbourne, Australia; 2012. Available from: http://apcollege.edu.au/pdf/media-other/paramedic-information-paramedics.org-australian-paramedical-college.apcollege.edu.au.pdf
  • Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA [Internet]. 2016 Feb 23;315(8):801. Available from: http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.0287
  • Neviere R. Sepsis syndromes in adults: Epidemiology, definitions, clinical presentation, diagnosis, and prognosis. In: Parsons PE, Finlay G, editors. UpToDate [Internet]. Waltham, MA: UpToDate; 202AD. Available from: www.uptodate.com/contents/sepsis-syndromes-in-adults-epidemiology-definitions-clinical-presentation-diagnosis-and-prognosis?search=sepsis-syndromes-in-adults-epidemiology-definitions-clinical-presentation-diagnosis
  • Epstein L, Dantes R, Magill S, Fiore A. Varying Estimates of Sepsis Mortality Using Death Certificates and Administrative Codes — United States, 1999–2014. MMWR Morb Mortal Wkly Rep [Internet]. 2016 Apr 8;65(13):342–5. Available from: http://www.cdc.gov/mmwr/volumes/65/wr/mm6513a2.htm
  • McPherson D, Griffiths C, Williams M, Baker A, Klodawski E, Jacobson B, et al. Sepsis-associated mortality in England: an analysis of multiple cause of death data from 2001 to 2010. BMJ Open [Internet]. 2013 Aug;3(8):e002586. Available from: http://bmjopen.bmj.com/lookup/doi/10.1136/bmjopen-2013-002586
  • Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. Lancet [Internet]. 2020 Jan;395(10219):200–11. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0140673619329897
  • Stearns-Kurosawa DJ, Osuchowski MF, Valentine C, Kurosawa S, Remick DG. The Pathogenesis of Sepsis. Annu Rev Pathol Mech Dis [Internet]. 2011 Feb 28;6(1):19–48. Available from: http://www.annualreviews.org/doi/10.1146/annurev-pathol-011110-130327
  • Neviere R. Pathophysiology of sepsis. In: Manaker S, Sexton DJ, Finlay G, editors. UpToDate [Internet]. Waltham, MA: UpToDate; 2020. Available from: www.uptodate.com/contents/pathophysiology-of-sepsis
  • Usman OA, Usman AA, Ward MA. Comparison of SIRS, qSOFA, and NEWS for the early identification of sepsis in the Emergency Department. Am J Emerg Med [Internet]. 2019 Aug;37(8):1490–7. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0735675718308891
  • Ferrer R, Martin-Loeches I, Phillips G, Osborn TM, Townsend S, Dellinger RP, et al. Empiric Antibiotic Treatment Reduces Mortality in Severe Sepsis and Septic Shock From the First Hour. Crit Care Med [Internet]. 2014 Aug;42(8):1749–55. Available from: http://journals.lww.com/00003246-201408000-00001
  • Seymour CW, Gesten F, Prescott HC, Friedrich ME, Iwashyna TJ, Phillips GS, et al. Time to Treatment and Mortality during Mandated Emergency Care for Sepsis. N Engl J Med [Internet]. 2017 Jun 8;376(23):2235–44. Available from: http://www.nejm.org/doi/10.1056/NEJMoa1703058
  • Whiles BB, Deis AS, Simpson SQ. Increased Time to Initial Antimicrobial Administration Is Associated With Progression to Septic Shock in Severe Sepsis Patients. Crit Care Med [Internet]. 2017 Apr;45(4):623–9. Available from: http://journals.lww.com/00003246-201704000-00008
  • Schmidt GA, Mandel J. Evaluation and management of suspected sepsis and septic shock in adults. In: Parsons PE, Sexton DJ, Hockberger RS, Finlay G, editors. UpToDate [Internet]. Waltham, MA: UpToDate; 2020. Available from: www.uptodate.com/contents/evaluation-and-management-of-suspected-sepsis-and-septic-shock-in-adults
  • Cecconi M, Evans L, Levy M, Rhodes A. Sepsis and septic shock. Lancet [Internet]. 2018 Jul;392(10141):75–87. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0140673618306962

References
References

Page contributors:

Matt Wilkinson-Stokes

Australian Catholic University

Want to help improve this article? Visit our Contribute page.

Clinical Resources Website

St John Ambulance Western Australia Ltd (ABN 55 028 468 715) (St John WA) operates ambulance and other pre-hospital clinical services. St John WA’s Clinical Resources, including its Clinical Practice Guidelines (Clinical Resources), are intended for use by credentialed St John WA staff and volunteers when providing clinical care to patients for or on behalf of St John WA, within the St John WA Clinical Governance Framework, and only to the extent of the clinician’s authority to practice.

Other users – Terms of Use

The content of the St John WA Clinical Resources is provided for information purposes only and is not intended to serve as health, medical or treatment advice. Any user of this website agrees to be bound by these Terms of Use in their use of the Clinical Resources.

St John WA does not represent or warrant (whether express, implied, statutory, or otherwise) that the content of the Clinical Resources is accurate, reliable, up-to-date, complete or that the information contained is suitable for your needs or for any particular purpose. You are responsible for assessing whether the information is accurate, reliable, up-to-date, authentic, relevant, or complete and where appropriate, seek independent professional advice.

St John WA expressly prohibits use of these Clinical Resources to guide clinical care of patients by organisations external to St John WA, except where these organisations have been directly engaged by St John WA to provide services. Any use of the Clinical Resources, with St John WA approval, must attribute St John WA as the creator of the Clinical Resources and include the copyright notice and (where reasonably practicable) provide a URL/hyperlink to the St John WA Clinical Resources website. 

No permission or licence is granted to reproduce, make commercial use of, adapt, modify or create derivative works from these Clinical Resources. For permissions beyond the scope of these Terms of Use, including a commercial licence, please contact medservices@stjohnambulance.com.au

Where links are provided to resources on external websites, St John WA:

  • Gives no assurances about the quality, accuracy or relevance of material on any linked site;
  • Accepts no legal responsibility regarding the accuracy and reliability of external material; and
  • Does not endorse any material, associated organisation, product or service on other sites.

Your use of any external website is governed by the terms of that website, including any authorisation, requirement or licence for use of the material on that website.

To the maximum extent permitted by law, St John WA excludes liability (including liability in negligence) for any direct, special, indirect, incidental, consequential, punitive, exemplary or other loss, cost, damage or expense arising out of, or in connection with, use or reliance on the Clinical Resources (including without limitation any interference with or damage to a user’s computer, device, software or data occurring in connection with such use).

Cookies

Please read this cookie policy carefully before using Clinical Resources from St John WA.

The cookies used on this site are small and completely anonymous pieces of information and are stored on your computer or mobile device. The data that the cookies contain identify your user preferences (such as your preferred text size, scope / skill level preference and Colour Assist mode, among other user settings) so that they can be recalled the next time that you visit a page within Clinical Resources. These cookies are necessary to offer you the best and most efficient possible experience when accessing and navigating through our website and using its features. These cookies do not collect or send analytical information back to St John WA.

Clinical Resources does integrate with Google Analytics and any cookies associated with this service enable us (and third-party services) to collect aggregated data for statistical purposes on how our visitors use this website. These cookies do not contain personal information such as names and email addresses and are used to help us improve your user experience of the website.

If you want to restrict or block the cookies that are set by our website, you can do so through your browser setting. Alternatively, you can visit www.internetcookies.com, which contains comprehensive information on how to do this on a wide variety of browsers and devices. You will find general information about cookies and details on how to delete cookies from your device. If you have any questions about this policy or our use of cookies, please contact us.

St John Ambulance Western Australia Ltd © Copyright 2020, All Rights Reserved

Terms of Use | Privacy Policy | Copyright Statement & Disclaimer